Liraglutide, a once-daily human GLP-1 analogue, provides sustained improvements in glycaemic control and weight for two years as monotherapy compared with glimepiride in patients with type 2 diabetes
You usually need to meet these conditions: A BMI of 35 or higher, or 30 or higher if you have other health problems like diabetes or heart disease You must have already tried to lose weight through diet, exercise, or other healthy changes You must go through a full health check with an NHS weight management service You must take part in a lifestyle change programme while using the medicine Important: There is often a waiting list for these NHS services
330 mg Other Ingredients: Glycerin, Water, Highly Purified Phospholipids, Ethanol, Tocofersolan, Naturl Mixed Tocopherols, Medium Chain Triglycerides, Natural Flavoring, EDTA (as preservative), Natural Citrus and Mint Oils
Li R.L., Wu S.S., Wu Y., et al
Legitimate products do not need to invent associations with prestigious institutions